KSKiyoko Sameshima

Kiyoko Sameshima

*This is an algorithmically generated author record based on publicly available information.

Kiyoko Sameshima has a total of 129 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Two siblings with 11qter deletion syndrome that had been rescued in their mother by uniparental disomy

    by Miki Kawai, Makiko Tsutsumi, Fumihiko Suzuki, Kiyoko Sameshima, Yuri Dowa, Takuji Kyoya, Hidehito Inagaki, Hiroki Kurahashi


  • Familial campomelic dysplasia due to maternal germinal mosaicism

    by Daisuke Higeta, Rie Yamaguchi, Takeshi Takagi, Gen Nishimura, Kiyoko Sameshima, Kayoko Saito, Takashi Minegishi

    Campomelic dysplasia is an autosomal dominant skeletal dysplasia caused by heterozygousSOX9mutations. Most patients are sporadic due to ade novomutation. Familial campomelic dysplasia is very rare. We report on a familial campomelic dysplasia caused by maternal germinal mosaicism. Two siblings showed the classic campomelic dysplasia phenotype with a novelSOX9mutation (NM_000346.3: c.441delC, p.(Asn147Lysfs*36)). Radiological examination of the mother showed mild skeletal changes. Then, her somatic mosaicism of the mutation was ascertained. This is the first report of molecularly confirmed maternal germinal mosaicism for aSOX9mutation. We suggest that a meticulous clinical examination of the parents, even if they are superficially healthy, is needed to avoid overlooking germinal mosaicism ofSOX9mutations.


  • Open Access

    Nationwide survey of Baller-Gerold syndrome in Japanese population

    by Hideo Kaneko, Rie Izumi, Hirotsugu Oda, Osamu Ohara, Kiyoko Sameshima, Hidenori Ohnishi, Toshiyuki Fukao, Michinori Funato

    Baller-Gerold syndrome (BGS) is a rare autosomal genetic disorder characterized by radial aplasia/hypoplasia and craniosynostosis. The causative gene for BGS encodes RECQL4, which belongs to the RecQ helicase family. To understand BGS patients in Japan, a nationwide survey was conducted, which identified 2 families and 3 patients affected by the syndrome. All the three patients showed radial defects and craniosynostosis. In one patient who showed a dislocated joint of the hip and flexion contracture of both the elbow joints and wrists at birth, a homozygous large deletion in the RECQL4 gene was identified. This is the first reported case of BGS in Japan caused by RECQL4 gene mutation.


  • A novel PLP1 frameshift mutation causing a milder form of Pelizaeus–Merzbacher disease

    by Takashi Shiihara, Mio Watanabe, Kengo Moriyama, Mitsugu Uematsu, Kiyoko Sameshima


  • The spectrum of ZEB2 mutations causing the Mowat–Wilson syndrome in Japanese populations

    by Yasukazu Yamada, Noriko Nomura, Kenichiro Yamada, Mari Matsuo, Yuka Suzuki, Kiyoko Sameshima, Reiko Kimura, Yuto Yamamoto, Daisuke Fukushi, Yayoi Fukuhara, et al.

    Mowat–Wilson syndrome (MWS) is a multiple congenital anomaly syndrome characterized by moderate or severe intellectual disability, a characteristic facial appearance, microcephaly, epilepsy, agenesis or hypoplasia of the corpus callosum, congenital heart defects, Hirschsprung disease, and urogenital/renal anomalies. It is caused by de novo heterozygous loss of function mutations including nonsense mutations, frameshift mutations, and deletions in ZEB2 at 2q22. ZEB2 encodes the zinc finger E‐box binding homeobox 2 protein consisting of 1,214 amino acids. Herein, we report 13 nonsense and 27 frameshift mutations from 40 newly identified MWS patients in Japan. Although the clinical findings of all the Japanese MWS patients with nonsense and frameshift mutations were quite similar to the previous review reports of MWS caused by nonsense mutations, frameshift mutations and deletions of ZEB2, the frequencies of microcephaly, Hirschsprung disease, and urogenital/renal anomalies were small. Patients harbored mutations spanning the region between the amino acids 55 and 1,204 in wild‐type ZEB2. There was no obvious genotype–phenotype correlation among the patients. A transfection study demonstrated that the cellular level of the longest form of the mutant ZEB2 protein harboring the p.D1204Rfs*29 mutation was remarkably low. The results showed that the 3′‐end frameshift mutation of ZEB2 causes MWS due to ZEB2 instability.


  • Liver disease is frequently observed in Down syndrome patients with transient abnormal myelopoiesis

    by Myoung Ja Park, Manabu Sotomatsu, Kentaro Ohki, Kokoro Arai, Kenichi Maruyama, Tomio Kobayashi, Akira Nishi, Kiyoko Sameshima, Takeshi Takagi, Yasuhide Hayashi

    Transient abnormal myelopoiesis (TAM) in neonates with Down syndrome (DS) is characterized by the transient appearance of blast cells, which resolves spontaneously. Approximately 20 % of patients with TAM die at an early age due to organ failure, including liver disease. We studied 25 DS-TAM patients retrospectively to clarify the correlation between clinical and laboratory characteristics and liver diseases. Early death (<6 months of age) occurred in four of the 25 patients (16.0 %), and two of those four patients died due to liver failure. Although physiologic jaundice improved gradually after a week, all DS patients had elevated D-Bil levels during the clinical course of TAM, except one who suffered early death. The median peak day of the WBC count, total bilirubin (T-Bil) and D-Bil levels was: day 1 (range day 0–57), day 8 (range day 1–55), and day 17 (range 1–53), respectively. Our results reveal that all patients with DS-TAM may develop liver disease irrespective of the absence or presence of symptoms and risk factors for early death. In patients of DS-TAM, careful observation of the level of D-Bil is needed by at least 1 month of age for the detection of liver disease risk.


  • Clinical consequences in truncating mutations in exon 34 of NOTCH2: Report of six patients with Hajdu–Cheney syndrome and a patient with serpentine fibula polycystic kidney syndrome

    by Yoko Narumi, Byung‐Joo Min, Kenji Shimizu, Itsuro Kazukawa, Kiyoko Sameshima, Koichi Nakamura, Tomoki Kosho, Yumie Rhee, Yoon‐Sok Chung, Ok‐Hwa Kim, et al.

    It is debatable whether Hajdu–Cheney syndrome (HCS) and serpentine fibula‐polycystic kidney syndrome (SFPKS) represent a single clinical entity with a variable degree of expression or two different entities, because both disorders share common clinical and radiological manifestations, including similar craniofacial characteristics, and defective bone mineralization. Since it was shown that heterozygous truncating mutations in NOTCH2 are responsible for both HCS and SFPKS, 37 patients with HCS and four patients with SFPKS are reported. To elucidate the clinical consequences of NOTCH2 mutations, we present detailed clinical information for seven patients with truncating mutations in exon 34 of NOTCH2, six with HCS and one with SFPKS. In addition, we review all the reported patients whose clinical manifestations are available. We found 13 manifestations including craniofacial features, acroosteolysis, Wormian bones, and osteoporosis in >75% of NOTCH2‐positive patients. Acroosteolysis was observed in two patients with SFPKS and bowing fibulae were found in two patients with HCS. These clinical and molecular data would support the notion that HCS and SFPKS are a single disorder.


  • Open Access

    Spastic quadriplegia in Down syndrome with congenital duodenal stenosis/atresia

    by Kenji Kurosawa, Keisuke Enomoto, Makiko Tominaga, Noritaka Furuya, Kiyoko Sameshima, Mizue Iai, Hiroshi Take, Masato Shinkai, Hiroshi Ishikawa, Michiko Yamanaka, et al.

    Down syndrome is an autosomal chromosome disorder, characterized by intellectual disability and muscle hypotonia. Muscle hypotonia is observed from neonates to adulthood in Down syndrome patients, but muscle hypertonicity is extremely unusual in this syndrome. During a study period of nine years, we found three patients with severe spastic quadriplegia among 20 cases with Down syndrome and congenital duodenal stenosis/atresia (3/20). However, we could find no patient with spastic quadriplegia among 644 cases with Down syndrome without congenital duodenal stenosis/atresia during the same period (0/644, P < 0.05). Further, we did not find any cases with spastic quadriplegia among 17 patients with congenital duodenal stenosis/atresia without Down syndrome admitted during the same period to use as a control group (0/17, P < 0.05). Our results suggest that congenital duodenal stenosis/atresia is a potential risk factor for spastic quadriplegia in patients with Down syndrome. Long‐term survival is improving, and the large majority of people with Down syndrome are expected to live well into adult life. Management and further study for the various problems, representing a low prevalence but serious and specific to patients with Down syndrome, are required to improve their quality of life.


    • 1 January 2012
      • Vol. 44  (1) , 35-40

    [Clinical characteristics of acute encephalopathies associated with influenza H1N1-2009 in children].

    by Yoshihiro Watanabe, Megumi Tsuji, Kiyoko Sameshima, Takahito Wada, Mizue Iai, Sumimasa Yamashita, Takuya Hayashi, Noriko Aida, Hitoshi Osaka

    We report 12 cases of acute encephalopathy associated with influenza H1N1-2009 treated according to Japanese guideline (2009). In all 12 cases, electroencephalogram presented diffuse or localized high-amplitude slow waves. Brain CT and MRI showed abnormalities in 4 and 6 cases, respectively. We used hypothermia therapy for 5 patients. One patient showed impairment in short term memory, while the rest of the patients showed no sequelae. These 12 cases presented here suggest the early recognition and therapy according to the newly proposed guideline may reduce severe sequelae and mortality by acute encephalopathy associated with influenza H1N1-2009.

  • 5,10-Methylenetetrahydrofolate reductase deficiency with progressive polyneuropathy in an infant

    by Megumi Tsuji, Atsushi Takagi, Kiyoko Sameshima, Mizue Iai, Sumimasa Yamashita, Hiroko Shinbo, Noritaka Furuya, Kenji Kurosawa, Hitoshi Osaka